Figure 1.

ATTRwt Amyloidosis Patient Enrollment and Participating Centers per Year

Participating centers in THAOS (the Transthyretin Amyloidosis Outcomes Survey) were centers with data available for patients with wild-type transthyretin amyloidosis (ATTRwt amyloidosis) in any given year. The number of participating centers with patients with ATTRwt amyloidosis grew from 3 in 2007 to 31 in 2019, and the number of new patient enrollments per year grew from 4 to 230. The average number of patients with ATTRwt amyloidosis enrolled per year per participating center has increased from <2 in 2007 and 2008 to >7 in 2018 and 2019.